All In MedTech

FDA Clearance Tracker · DEN220006

ProdiGI

A De Novo grant creates a new device type for a low to moderate risk device with nothing on the market to compare it to. Later devices of this type can use it as their comparison in a 510(k).

Last checked: Nov 20, 2026Latest source record: Jun 13, 2022 (this decision)Source: openFDAMethods & limitations

De NovoNew device type

The decision

FDA number
DEN220006
Device name
ProdiGI
Applicant
Covidien, LLC
Applicant location
Santa Clara, CA
Received
Jan 14, 2022
Decided
Jun 13, 2022
Decision
De Novo granted
Submission type
Direct

Device type

Device class
Class II
Regulation
21 CFR 876.4410

Every decision under product code QSW

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Covidien, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.